3-[4-(1-thiophen-2-ylmethyl-1H-indol-3-yl)-piperidin-1-ylmethyl]-benzoic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 3-[4-(1-thiophen-2-ylmethyl-1H-indol-3-yl)-piperidin-1-ylmethyl]-benzoic acid
• 英文别名: 3-[4-(1-thiophen-2-ylmethyl-1H-indol-3-yl)piperidin-1-ylmethyl]benzoic acid；3-[[4-[1-(thiophen-2-ylmethyl)indol-3-yl]piperidin-1-yl]methyl]benzoic acid
• 化学式: C₂₆H₂₆N₂O₂S
• 分子量: 430.571
• InChiKey: IZCYYVKHBBLUDY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  31
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  73.7
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  4-氧代哌啶酮盐酸盐 在 palladium on activated charcoal 盐酸 、 氢氧化钾 、 氢气 、 sodium hydride 、 三乙胺 、 potassium iodide 作用下， 以 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 、 异丙醇 为溶剂， 90.0 ℃ 、300.0 kPa 条件下， 反应 65.5h， 生成 3-[4-(1-thiophen-2-ylmethyl-1H-indol-3-yl)-piperidin-1-ylmethyl]-benzoic acid
  参考文献：
  名称：

  新型组胺H1拮抗剂：吲哚基哌啶基苯甲酸衍生物的合成与构效关系。

  摘要：

  制备了一系列的吲哚基哌啶基衍生物，并对其作为组胺H（1）拮抗剂的活性进行了评估。结构-活性关系研究旨在提高我们的第一个前导分子的体内活性和药代动力学特征（1）。吲哚环上位置6上的氟取代在抑制组胺诱导的皮肤血管通透性测定中导致较高的体内活性，但对5HT（2）受体的选择性较低。在该系列中进行了广泛的优化，并鉴定了许多组胺H（1）拮抗剂，这些拮抗剂在体内具有强大的作用力和作用时间长，脑渗透力低或具有心脏毒性的潜力。在这个新系列中，吲哚基哌啶15、20、48、51和52在大鼠中显示出长的半衰期，并已被选择用于进一步的临床前评估。

  DOI：

  10.1021/jm0498203

文献信息

• Indolylpiperidine derivatives as antihistaminic aand antiallergic agents
  申请人：——

  公开号：US20040116471A1

  公开（公告）日：2004-06-17

  The invention relates to indolyl piperidinyl derivatives of formula (I) wherein: A 1 represents an alkylene, alkyleneoxy, alkylenethio, alkanoylene or hydroxyalkylene group; A 2 represents an alkylene, alkyleneoxy, alkylenethio, alkanoylene or an alkyleneoxyalkylene group; W 1 represents a phenylene, furanylene or pyridinylene group which is unsubstituted or substituted by one or more halogen atoms, alkoxy groups and/or alkyl groups; W 2 represents a 3-10 membered monocyclic or bicyclic group containing from 1 to 3 heteroatoms said group being unsubstituted or substituted by one or more halogen atoms, alkyl groups, alkoxy groups and/or oxo groups; R 1 represents a hydrogen or halogen atom or an alkyl, alkoxy or methylamino group; and R 2 represents a carboxyl group; and pharmaceutically acceptable salts thereof; to processes for their preparation; to pharmaceutical compositions containing them; and to their medical use as antihistaminic and antiallergic agents.

  该发明涉及式(I)的吲哚基哌啶衍生物，其中：A1代表烷基、烷氧基、硫代烷基、烷酰基或羟基烷基基团；A2代表烷基、烷氧基、硫代烷基、烷酰基或烷氧基烷基基团；W1代表苯基、呋喃基或吡啶基，该基团未取代或被一个或多个卤素原子、烷氧基和/或烷基取代；W2代表含有1至3个杂原子的3-10元成员的单环或双环基团，该基团未取代或被一个或多个卤素原子、烷基、烷氧基和/或氧代基取代；R1代表氢原子或卤素原子或烷基、烷氧基或甲氧基氨基基团；R2代表羧基；及其药学上可接受的盐；其制备方法；含有它们的药物组合物；以及它们作为抗组胺和抗过敏药物的医药用途。
• Indolylpiperidine derivatives as antihistaminic and antiallergic agents
  申请人：Almirall Prodesfarma S.A.

  公开号：US07189741B2

  公开（公告）日：2007-03-13

  The invention relates to indolyl piperidinyl derivatives of formula (I) wherein: A1 represents an alkylene, alkyleneoxy, alkylenethio, alkanoylene or hydroxyalkylene group; A2 represents an alkylene, alkyleneoxy, alkylenethio, alkanoylene or an alkyleneoxyalkylene group; W1 represents a phenylene, furanylene or pyridinylene group which is unsubstituted or substituted by one or more halogen atoms, alkoxy groups and/or alkyl groups; W2 represents a 3–10 membered monocyclic or bicyclic group containing from 1 to 3 heteroatoms said group being unsubstituted or substituted by one or more halogen atoms, alkyl groups, alkoxy groups and/or oxo groups; R1 represents a hydrogen or halogen atom or an alkyl, alkoxy or methylamino group; and R2 represents a carboxyl group; and pharmaceutically acceptable salts thereof; to processes for their preparation; to pharmaceutical compositions containing them; and to their medical use as antihistaminic and antiallergic agents.

  本发明涉及式（I）的吲哚基哌啶衍生物，其中：A1代表烷基，烷氧基，烷硫基，酰基烷基或羟基烷基；A2代表烷基，烷氧基，烷硫基，酰基烷基或烷氧基烷基；W1代表苯基，呋喃基或吡啶基，其未取代或被一个或多个卤素原子，烷氧基和/或烷基取代；W2代表一个含1-3个杂原子的3-10环的单环或双环基团，其未取代或被一个或多个卤素原子，烷基，烷氧基和/或氧代基取代；R1代表氢或卤素原子或烷基，烷氧基或甲基氨基基团；R2代表羧基；以及其药学上可接受的盐；本发明还涉及制备它们的过程，含有它们的制药组合物以及它们作为抗组胺和抗过敏剂的医药用途。
• INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS
  申请人：Almirall Prodesfarma, S.A.

  公开号：EP1330453B1

  公开（公告）日：2006-03-29
• US7189741B2
  申请人：——

  公开号：US7189741B2

  公开（公告）日：2007-03-13
• [EN] INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS<br/>[FR] DERIVES D'INDOLYLPIPERIDINE UTILISES COMME AGENTS ANTIHISTAMINIQUES ET ANTIALLERGIQUES
  申请人：ALMIRALL PRODESFARMA SA

  公开号：WO2002036589A1

  公开（公告）日：2002-05-10

  The invention relates to indolyl piperidinyl derivatives of formula (I) wherein: A1 represents an alkylene, alkyleneoxy, alkylenethio, alkanoylene or hydroxyalkylene group; A2 represents an alkylene, alkyleneoxy, alkylenethio, alkanoylene or an alkyleneoxyalkylene group; W1 represents a phenylene, furanylene or pyridinylene group which is unsubstituted or substituted by one or more halogen atoms, alkoxy groups and/or alkyl groups; W2 represents a 3-10 membered monocyclic or bicyclic group containing from 1 to 3 heteroatoms said group being unsubstituted or substituted by one or more halogen atoms, alkyl groups, alkoxy groups and/or oxo groups; R1 represents a hydrogen or halogen atom or an alkyl, alkoxy or methylamino group; and R2 represents a carboxyl group; and pharmaceutically acceptable salts thereof; to processes for their preparation; to pharmaceutical compositions containing them; and to their medical use as antihistaminic and antiallergic agents.